FDA Approval Summary: Olaparib in Combination with Abiraterone for Treatment of Patients with BRCA-Mutated Metastatic Castration-Resistant Prostate Cancer.Jaleh Fallah,Jianjin Xu,Chana Weinstock,Michael H. Brave,Erik Bloomquist,Mallorie H. Fiero, Timothy Schaefer,Anand Pathak, Abdelrahmman Abukhdeir,Vishal Bhatnagar,Haw-Jyh Chiu,Tiffany Ricks, Christy John,Salaheldin Hamed, Christal Lee,William F. Pierce,Shyam Kalavar,Reena Philip,Shenghui Tang,Laleh Amiri-Kordestani,Richard Pazdur,Paul G. Kluetz,Daniel SuzmanJournal of Clinical Oncology（2023）引用 11|浏览25AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
